Trial Profile
Clinical Trials Insight: 700007513
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2005
Price :
$35
*
At a glance
- Drugs Rinfabate (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 10 Nov 2005 New trial record.